Trump's Marijuana Reclassification Could Unlock Cannabis Industry Growth episode artwork

EPISODE · Dec 12, 2025 · 2 MIN

Trump's Marijuana Reclassification Could Unlock Cannabis Industry Growth

from Cannabis Industry News · host Inception Point AI

In the past 48 hours, the cannabis industry buzzes with anticipation over President Trumps expected directive to reclassify marijuana from Schedule I to Schedule III, as reported by the Washington Post on December 11. This move, discussed in a December 10 call with House Speaker Mike Johnson, industry executives, Health Secretary Robert F. Kennedy Jr., and Mehmet Oz, could end 50-year-old restrictions, recognize medical use, and lift IRS code 280E tax burdens that have crippled operators[1][6]. Unlike stalled prior efforts paused by a DEA judge since 2023, this signals swift executive action, potentially unlocking banking and capital flows in a sector long starved of them[1][6]. Aurora Cannabis expanded aggressively internationally, launching high-potency Black Jelly flower in Poland on December 11 with 27 percent THC, joining its Farm Gas and Sourdough lineup from EU-GMP facilities, amid Trump rescheduling reports[2][7]. They also announced a distribution partnership with Leafio Australia. Domestically, Smokiez Gummies surged in New Jersey via a deal with a Real Housewives-backed company, while Cheech and Chong launched a co-branded dispensary network challenging multi-state operators[4][10]. Regulatory wins include Massachusetts Cannabis Control Commission unanimously approving on-site consumption licenses on December 11, creating three new types for adults 21-plus at events and partner venues in its 8 billion dollar market, after two years of input[5]. A coalition filed an amicus brief on December 11 challenging 280E taxes in Tax Court[9]. Federally, Sens. Wyden and Merkley introduced a hemp bill on December 11 to replace Trumps THC ban with 5 mg per serving limits[3]. No major market disruptions or verified stock stats emerged in the last week, but premium products like infused pre-rolls gain share amid consumer shifts to wellness[6]. Holiday deals, like Purple Lotuss 40 percent off Stiiizy and Alien Labs in San Jose starting December 13, signal stable supply chains[8]. Compared to last weeks hemp ban focus, reclassification now dominates, positioning leaders like Aurora for global growth while states innovate locally. This pivotal shift could transform a fragmented industry into a mature one by year-end[1][6]. (Word count: 348) For great deals today, check out https://amzn.to/44ci4hQ This content was created in partnership and with the help of Artificial Intelligence AI.

In the past 48 hours, the cannabis industry buzzes with anticipation over President Trumps expected directive to reclassify marijuana from Schedule I to Schedule III, as reported by the Washington Post on December 11. This move, discussed in a December 10 call with House Speaker Mike Johnson, industry executives, Health Secretary Robert F. Kennedy Jr., and Mehmet Oz, could end 50-year-old restrictions, recognize medical use, and lift IRS code 280E tax burdens that have crippled operators[1][6]. Unlike stalled prior efforts paused by a DEA judge since 2023, this signals swift executive action, potentially unlocking banking and capital flows in a sector long starved of them[1][6]. Aurora Cannabis expanded aggressively internationally, launching high-potency Black Jelly flower in Poland on December 11 with 27 percent THC, joining its Farm Gas and Sourdough lineup from EU-GMP facilities, amid Trump rescheduling reports[2][7]. They also announced a distribution partnership with Leafio Australia. Domestically, Smokiez Gummies surged in New Jersey via a deal with a Real Housewives-backed company, while Cheech and Chong launched a co-branded dispensary network challenging multi-state operators[4][10]. Regulatory wins include Massachusetts Cannabis Control Commission unanimously approving on-site consumption licenses on December 11, creating three new types for adults 21-plus at events and partner venues in its 8 billion dollar market, after two years of input[5]. A coalition filed an amicus brief on December 11 challenging 280E taxes in Tax Court[9]. Federally, Sens. Wyden and Merkley introduced a hemp bill on December 11 to replace Trumps THC ban with 5 mg per serving limits[3]. No major market disruptions or verified stock stats emerged in the last week, but premium products like infused pre-rolls gain share amid consumer shifts to wellness[6]. Holiday deals, like Purple Lotuss 40 percent off Stiiizy and Alien Labs in San Jose starting December 13, signal stable supply chains[8]. Compared to last weeks hemp ban focus, reclassification now dominates, positioning leaders like Aurora for global growth while states innovate locally. This pivotal shift could transform a fragmented industry into a mature one by year-end[1][6]. (Word count: 348) For great deals today, check out https://amzn.to/44ci4hQ This content was created in partnership and with the help of Artificial Intelligence AI.

NOW PLAYING

Trump's Marijuana Reclassification Could Unlock Cannabis Industry Growth

0:00 2:39

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Cannabis Industry News?

This episode is 2 minutes long.

When was this Cannabis Industry News episode published?

This episode was published on December 12, 2025.

What is this episode about?

In the past 48 hours, the cannabis industry buzzes with anticipation over President Trumps expected directive to reclassify marijuana from Schedule I to Schedule III, as reported by the Washington Post on December 11. This move, discussed in a...

Can I download this Cannabis Industry News episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!